{"transactions":[{"id":1099480,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-30T20:09:44.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":23000,"derivative":{"exercise_price":0.74,"expiration_date":"2035-06-25","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000950170-25-091562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017025091562/ownership.xml","form_type":"4"}},{"id":1099479,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-06-30T20:09:44.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0000950170-25-091562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017025091562/ownership.xml","form_type":"4"}},{"id":1114683,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-11T17:14:24.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":53600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":53600,"derivative":{"exercise_price":3.92,"exercise_date":"2026-06-10","expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":53600},"source":{"system":"sec-edgar","filing":"0001562180-25-004719","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218025004719/primarydocument.xml","form_type":"4"}},{"id":1114682,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T17:14:24.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":35700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":152830,"source":{"system":"sec-edgar","filing":"0001562180-25-004719","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218025004719/primarydocument.xml","form_type":"4"}},{"id":1384395,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-18T20:05:12.000Z","date":"2024-10-16","kind":"exercise","planned":true,"acquired":true,"shares":5833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company."}],"balance_after":0,"derivative":{"exercise_price":13.05,"expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":5833},"source":{"system":"sec-edgar","filing":"0001140361-24-043695","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124043695/form4.xml","form_type":"4"}},{"id":1384394,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-18T20:05:12.000Z","date":"2024-10-16","kind":"sale","planned":true,"acquired":false,"shares":5833,"price":41.36,"value":241252.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001140361-24-043695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124043695/form4.xml","form_type":"4"}},{"id":1384393,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-18T20:05:12.000Z","date":"2024-10-16","kind":"exercise","planned":true,"acquired":true,"shares":5833,"price":13.05,"value":76120.65,"ownership":{"direct":true},"balance_after":16833,"source":{"system":"sec-edgar","filing":"0001140361-24-043695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124043695/form4.xml","form_type":"4"}},{"id":1391074,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-04T20:06:49.000Z","date":"2024-10-02","kind":"exercise","planned":true,"acquired":true,"shares":5833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company."}],"balance_after":5833,"derivative":{"exercise_price":13.05,"expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":5833},"source":{"system":"sec-edgar","filing":"0001140361-24-042882","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124042882/form4.xml","form_type":"4"}},{"id":1391073,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-04T20:06:49.000Z","date":"2024-10-02","kind":"sale","planned":true,"acquired":false,"shares":5833,"price":40.35,"value":235361.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001140361-24-042882","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124042882/form4.xml","form_type":"4"}},{"id":1391072,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-04T20:06:49.000Z","date":"2024-10-02","kind":"exercise","planned":true,"acquired":true,"shares":5833,"price":13.05,"value":76120.65,"ownership":{"direct":true},"balance_after":16833,"source":{"system":"sec-edgar","filing":"0001140361-24-042882","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124042882/form4.xml","form_type":"4"}},{"id":1401958,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-20T20:05:24.000Z","date":"2024-09-18","kind":"exercise","planned":true,"acquired":true,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company."}],"balance_after":11666,"derivative":{"exercise_price":13.05,"expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001140361-24-041562","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124041562/form4.xml","form_type":"4"}},{"id":1401957,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-20T20:05:24.000Z","date":"2024-09-18","kind":"sale","planned":true,"acquired":false,"shares":5834,"price":45.54,"value":265680.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001140361-24-041562","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124041562/form4.xml","form_type":"4"}},{"id":1401956,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-20T20:05:24.000Z","date":"2024-09-18","kind":"exercise","planned":true,"acquired":true,"shares":5834,"price":13.05,"value":76133.7,"ownership":{"direct":true},"balance_after":16834,"source":{"system":"sec-edgar","filing":"0001140361-24-041562","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124041562/form4.xml","form_type":"4"}},{"id":1414636,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-05T20:06:32.000Z","date":"2024-09-04","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options, representing the right to purchase 5,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025."}],"balance_after":0,"derivative":{"exercise_price":3.74,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-24-040228","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124040228/form4.xml","form_type":"4"}},{"id":1414635,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-05T20:06:32.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":48.58,"value":242900.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001140361-24-040228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124040228/form4.xml","form_type":"4"}},{"id":1414634,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-05T20:06:32.000Z","date":"2024-09-04","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":3.74,"value":18700.0,"ownership":{"direct":true},"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001140361-24-040228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124040228/form4.xml","form_type":"4"}},{"id":1472329,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-21T20:08:42.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":23000,"derivative":{"exercise_price":1.88,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000950170-24-076235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017024076235/ownership.xml","form_type":"4"}},{"id":1472328,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-21T20:08:42.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":47000,"source":{"system":"sec-edgar","filing":"0000950170-24-076235","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017024076235/ownership.xml","form_type":"4"}},{"id":1484586,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-06-10T16:19:30.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.07,"exercise_date":"2025-06-06","expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-24-004906","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218024004906/primarydocument.xml","form_type":"4"}},{"id":1484585,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T16:19:30.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":117130,"source":{"system":"sec-edgar","filing":"0001562180-24-004906","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218024004906/primarydocument.xml","form_type":"4"}},{"id":1529320,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2024-05-03T20:06:05.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":3200,"derivative":{"underlying":"Common Stock","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0001140361-24-024332","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124024332/form4.xml","form_type":"4"}},{"id":1529319,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T20:06:05.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company."}],"balance_after":8000,"derivative":{"exercise_price":47.08,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001140361-24-024332","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124024332/form4.xml","form_type":"4"}},{"id":1529318,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2024-05-03T20:06:05.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest 100% on the earlier of May 3, 2024, or the date of the first Annual Meeting of Stockholders following May 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0001140361-24-024332","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124024332/form4.xml","form_type":"4"}},{"id":1529317,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-03T20:06:05.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":3200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on May 3, 2023."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001140361-24-024332","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124024332/form4.xml","form_type":"4"}},{"id":1845518,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-23T20:12:44.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0000950170-23-029622","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017023029622/ownership.xml","form_type":"4"}},{"id":1850101,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-21T00:00:37.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":2.74,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-23-029037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017023029037/ownership.xml","form_type":"4"}},{"id":1861902,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-06-08T16:07:07.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.2,"exercise_date":"2024-06-06","expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-23-004954","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218023004954/primarydocument.xml","form_type":"4"}},{"id":1861901,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T16:07:07.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":87130,"source":{"system":"sec-edgar","filing":"0001562180-23-004954","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218023004954/primarydocument.xml","form_type":"4"}},{"id":1903478,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-05-05T20:04:56.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest 100% on the earlier of May 3, 2024 or the date of the first Annual Meeting of Stockholders following May 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":3200,"derivative":{"underlying":"Common Stock","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0001140361-23-023193","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036123023193/form4.xml","form_type":"4"}},{"id":1903477,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-05T20:04:56.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company."}],"balance_after":8000,"derivative":{"exercise_price":32.12,"expiration_date":"2033-05-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001140361-23-023193","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036123023193/form4.xml","form_type":"4"}},{"id":1911705,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-04-28T20:04:35.000Z","date":"2023-04-27","kind":"exercise","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001140361-23-021499","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036123021499/form4.xml","form_type":"4"}},{"id":1911704,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-28T20:04:35.000Z","date":"2023-04-27","kind":"exercise","planned":false,"acquired":true,"shares":2600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 27, 2022."}],"balance_after":7800,"source":{"system":"sec-edgar","filing":"0001140361-23-021499","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036123021499/form4.xml","form_type":"4"}},{"id":2224434,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-22T20:03:30.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":1.78,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-038657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919122038657/doc4.xml","form_type":"4"}},{"id":2224433,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-22T20:03:30.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-22-038657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919122038657/doc4.xml","form_type":"4"}},{"id":2237366,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-06-09T16:58:04.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":0.45,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-22-004975","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218022004975/primarydocument.xml","form_type":"4"}},{"id":2237365,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T16:58:04.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the \"2014 Plan\"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":57130,"source":{"system":"sec-edgar","filing":"0001562180-22-004975","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218022004975/primarydocument.xml","form_type":"4"}},{"id":2239974,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T16:03:57.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":4567,"price":0.362,"value":1653.254,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 2, 2021."}],"balance_after":43430,"source":{"system":"sec-edgar","filing":"0001562180-22-004870","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218022004870/primarydocument.xml","form_type":"4"}},{"id":2265604,"issuer":{"id":116797,"kind":"organization","name":"CONTRAFECT Corp","symbol":"CFRX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2022-05-18T18:04:26.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":42000,"price":3.35,"value":140700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant award made under the ContraFect Corporation 2014 Omnibus Incentive Plan.  Grant vests over one year, 25% at the end of each quarter following the vesting commencement date."}],"balance_after":42000,"derivative":{"exercise_price":3.35,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001209191-22-030206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478069/000120919122030206/doc4.xml","form_type":"4"}},{"id":2287033,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T20:07:38.000Z","date":"2022-04-29","kind":"sale","acquired":false,"shares":900,"price":30.94,"value":27846.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."}],"balance_after":5200,"source":{"system":"sec-edgar","filing":"0001593968-22-000897","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396822000897/primary_01.xml","form_type":"4"}},{"id":2288290,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-04-29T20:12:20.000Z","date":"2022-04-27","kind":"grant","acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":2600,"derivative":{"underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001593968-22-000891","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396822000891/primary_01.xml","form_type":"4"}},{"id":2288289,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-29T20:12:20.000Z","date":"2022-04-27","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company."}],"balance_after":6500,"derivative":{"exercise_price":31.99,"expiration_date":"2032-04-27","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001593968-22-000891","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396822000891/primary_01.xml","form_type":"4"}},{"id":2288288,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-04-29T20:12:20.000Z","date":"2022-04-27","kind":"exercise","acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest 100% on the earlier of April 28, 2022 or the date of the first Annual Meeting of Stockholders following April 28, 2021. The first Annual Meeting of Stockholders occurred on April 27, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001593968-22-000891","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396822000891/primary_01.xml","form_type":"4"}},{"id":2288287,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T20:12:20.000Z","date":"2022-04-27","kind":"exercise","acquired":true,"shares":2600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 28, 2021."}],"balance_after":6100,"source":{"system":"sec-edgar","filing":"0001593968-22-000891","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396822000891/primary_01.xml","form_type":"4"}},{"id":2491204,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-01T21:07:45.000Z","date":"2021-11-29","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options, representing the right to purchase a total of 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015 and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017."}],"balance_after":0,"derivative":{"exercise_price":3.74,"expiration_date":"2025-03-20","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001593968-21-002478","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821002478/primary_01.xml","form_type":"4"}},{"id":2491203,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T21:07:45.000Z","date":"2021-11-29","kind":"sale","acquired":false,"shares":5000,"price":39.171,"value":195855.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001593968-21-002478","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821002478/primary_01.xml","form_type":"4"}},{"id":2491202,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T21:07:45.000Z","date":"2021-11-29","kind":"exercise","acquired":true,"shares":5000,"price":3.74,"value":18700.0,"ownership":{"direct":true},"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001593968-21-002478","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821002478/primary_01.xml","form_type":"4"}},{"id":2533142,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-28T20:12:58.000Z","date":"2021-10-27","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options, representing the right to purchase a total of 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015 and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017."}],"balance_after":5000,"derivative":{"exercise_price":3.74,"expiration_date":"2025-03-20","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001593968-21-002304","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821002304/primary_01.xml","form_type":"4"}},{"id":2533141,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-28T20:12:58.000Z","date":"2021-10-27","kind":"sale","acquired":false,"shares":5000,"price":50.574,"value":252870.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001593968-21-002304","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821002304/primary_01.xml","form_type":"4"}},{"id":2533140,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-28T20:12:58.000Z","date":"2021-10-27","kind":"exercise","acquired":true,"shares":5000,"price":3.74,"value":18700.0,"ownership":{"direct":true},"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001593968-21-002304","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821002304/primary_01.xml","form_type":"4"}},{"id":2555183,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-01T20:12:33.000Z","date":"2021-09-30","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options, representing the right to purchase a total of 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015 and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017."}],"balance_after":10000,"derivative":{"exercise_price":3.74,"expiration_date":"2025-03-20","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001593968-21-002214","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821002214/primary_01.xml","form_type":"4"}},{"id":2555182,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T20:12:33.000Z","date":"2021-09-30","kind":"sale","acquired":false,"shares":5000,"price":48.851,"value":244255.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001593968-21-002214","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821002214/primary_01.xml","form_type":"4"}},{"id":2555181,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T20:12:33.000Z","date":"2021-09-30","kind":"exercise","acquired":true,"shares":5000,"price":3.74,"value":18700.0,"ownership":{"direct":true},"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001593968-21-002214","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821002214/primary_01.xml","form_type":"4"}},{"id":2661559,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T12:29:00.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":7.51,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-041822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919121041822/doc4.xml","form_type":"4"}},{"id":2675209,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-09T16:26:29.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":4567,"price":3.3202,"value":15163.3534,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 5, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.3201 USD to $3.325 USD; the price reported above reflects the weighted average sale price."}],"balance_after":47997,"source":{"system":"sec-edgar","filing":"0001562180-21-004152","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218021004152/primarydocument.xml","form_type":"4"}},{"id":2682608,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-06-03T17:26:50.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":3.37,"exercise_date":"2022-06-02","expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-21-004027","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218021004027/primarydocument.xml","form_type":"4"}},{"id":2682607,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T17:26:50.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the \"2014 Plan\"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":52564,"source":{"system":"sec-edgar","filing":"0001562180-21-004027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218021004027/primarydocument.xml","form_type":"4"}},{"id":2703093,"issuer":{"id":116797,"kind":"organization","name":"CONTRAFECT Corp","symbol":"CFRX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2021-05-20T19:48:10.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant award made under the ContraFect Corporation Omnibus Incentive Plan.  Grant vests over one year, 25% at the end of each quarter following the vesting commencement date."}],"balance_after":25000,"derivative":{"exercise_price":3.86,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-034651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478069/000120919121034651/doc4.xml","form_type":"4"}},{"id":2735046,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-30T20:02:40.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company."}],"balance_after":6500,"derivative":{"exercise_price":63.22,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001593968-21-001206","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821001206/primary_01.xml","form_type":"4"}},{"id":2735045,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-04-30T20:02:40.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest 100% on the earlier of April 28, 2022 or the date of the first Annual Meeting of Stockholders following April 28, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":2600,"derivative":{"underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001593968-21-001206","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821001206/primary_01.xml","form_type":"4"}},{"id":2735044,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-04-30T20:02:40.000Z","date":"2021-04-28","kind":"exercise","acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest 100% on the earlier of April 29, 2021 or the date of the first Annual Meeting of Stockholders following April 29, 2020. The first Annual Meeting of Stockholders occurred on April 28, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001593968-21-001206","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821001206/primary_01.xml","form_type":"4"}},{"id":2735043,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-30T20:02:40.000Z","date":"2021-04-28","kind":"exercise","acquired":true,"shares":1750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on April 29, 2020."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001593968-21-001206","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396821001206/primary_01.xml","form_type":"4"}},{"id":2766653,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-31T20:02:07.000Z","date":"2020-07-06","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":55000,"derivative":{"exercise_price":0.73,"expiration_date":"2030-07-05","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-21-023758","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919121023758/doc4a.xml","form_type":"4/A","original_submission_date":"2020-07-06"}},{"id":2933303,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-12-23T14:06:31.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 21, 2020 of 4,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant)."}],"balance_after":2000,"derivative":{"exercise_price":8.25,"exercise_date":"2020-12-21","expiration_date":"2024-06-21","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-20-064956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120064956/doc4.xml","form_type":"4"}},{"id":2933302,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2020-12-23T14:06:31.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 21, 2020 of 4,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant)."}],"balance_after":2000,"derivative":{"exercise_price":7.33,"exercise_date":"2020-12-21","expiration_date":"2021-12-21","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-20-064956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120064956/doc4.xml","form_type":"4"}},{"id":2933301,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-23T14:06:31.000Z","date":"2020-12-21","kind":"purchase","acquired":true,"shares":4000,"price":6.25,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 21, 2020 of 4,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant)."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-20-064956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120064956/doc4.xml","form_type":"4"}},{"id":3018379,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:14:42.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":38.09,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-010061","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010061/edgar.xml","form_type":"4"}},{"id":3018378,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:14:42.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":12.64,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-010061","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010061/edgar.xml","form_type":"4"}},{"id":3018377,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:14:42.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":8855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":22.3,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":8855},"source":{"system":"sec-edgar","filing":"0001179110-20-010061","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010061/edgar.xml","form_type":"4"}},{"id":3018376,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:14:42.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":11207,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":17.2,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":11207},"source":{"system":"sec-edgar","filing":"0001179110-20-010061","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010061/edgar.xml","form_type":"4"}},{"id":3018375,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T17:14:42.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":7796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of August 19, 2020 (the \"Merger Agreement\"), by and among Johnson & Johnson, Vigor Sub, Inc. (\"Merger Sub\") and the Issuer, including the completion of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $52.50 per share in cash, without interest, less any required withholding taxes (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Merger Sub on October 1, 2020.  Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-010061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010061/edgar.xml","form_type":"4"}},{"id":3064588,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-07T17:04:18.000Z","date":"2020-08-05","kind":"exercise","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020"}],"balance_after":0,"derivative":{"exercise_price":10.63,"exercise_date":"2019-06-22","expiration_date":"2026-06-22","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001179110-20-008799","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008799/edgar.xml","form_type":"4"}},{"id":3064587,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-07T17:04:18.000Z","date":"2020-08-05","kind":"sale","acquired":false,"shares":13000,"price":32.75,"value":425750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.27 to $32.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7796,"source":{"system":"sec-edgar","filing":"0001179110-20-008799","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008799/edgar.xml","form_type":"4"}},{"id":3064586,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-07T17:04:18.000Z","date":"2020-08-05","kind":"exercise","acquired":true,"shares":13000,"price":10.63,"value":138190.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020"}],"balance_after":20796,"source":{"system":"sec-edgar","filing":"0001179110-20-008799","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008799/edgar.xml","form_type":"4"}},{"id":3073280,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-30T19:03:04.000Z","date":"2020-07-29","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020"}],"balance_after":13000,"derivative":{"exercise_price":10.63,"exercise_date":"2018-06-22","expiration_date":"2026-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-008585","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008585/edgar.xml","form_type":"4"}},{"id":3073279,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-30T19:03:04.000Z","date":"2020-07-29","kind":"sale","acquired":false,"shares":10000,"price":29.7,"value":297000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $29.20 to $30.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7796,"source":{"system":"sec-edgar","filing":"0001179110-20-008585","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008585/edgar.xml","form_type":"4"}},{"id":3073278,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-30T19:03:04.000Z","date":"2020-07-29","kind":"exercise","acquired":true,"shares":10000,"price":10.63,"value":106300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020"}],"balance_after":17796,"source":{"system":"sec-edgar","filing":"0001179110-20-008585","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008585/edgar.xml","form_type":"4"}},{"id":3076841,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-23T17:55:42.000Z","date":"2020-07-22","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020"}],"balance_after":23000,"derivative":{"exercise_price":10.63,"exercise_date":"2017-06-22","expiration_date":"2026-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-008471","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008471/edgar.xml","form_type":"4"}},{"id":3076840,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-23T17:55:42.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":10000,"price":33.23,"value":332300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.51 to $33.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7796,"source":{"system":"sec-edgar","filing":"0001179110-20-008471","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008471/edgar.xml","form_type":"4"}},{"id":3076839,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-23T17:55:42.000Z","date":"2020-07-22","kind":"grant","acquired":true,"shares":10000,"price":10.63,"value":106300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020"}],"balance_after":17796,"source":{"system":"sec-edgar","filing":"0001179110-20-008471","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008471/edgar.xml","form_type":"4"}},{"id":3086792,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-08T20:09:02.000Z","date":"2020-07-06","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":45000,"derivative":{"exercise_price":0.73,"expiration_date":"2030-07-05","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-20-041735","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120041735/doc4.xml","form_type":"4"}},{"id":3100740,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T17:46:59.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gilman's continued service to the Company."}],"balance_after":25000,"derivative":{"exercise_price":38.09,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-007757","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020007757/edgar.xml","form_type":"4"}},{"id":3115909,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-06-09T16:17:45.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Stock Option\"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":11.96,"exercise_date":"2021-06-05","expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-20-004359","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218020004359/primarydocument.xml","form_type":"4"}},{"id":3115908,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T16:17:45.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":4567,"price":12.08,"value":55169.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 6, 2019."}],"balance_after":38864,"source":{"system":"sec-edgar","filing":"0001562180-20-004359","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218020004359/primarydocument.xml","form_type":"4"}},{"id":3115907,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T16:17:45.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"RSUs\"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":43431,"source":{"system":"sec-edgar","filing":"0001562180-20-004359","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218020004359/primarydocument.xml","form_type":"4"}},{"id":3165807,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-05-01T20:15:57.000Z","date":"2020-04-29","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest 100% on the earlier of April 29, 2021 or the date of the first Annual Meeting of Stockholders following April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":1750,"derivative":{"underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001593968-20-001089","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396820001089/primary_01.xml","form_type":"4"}},{"id":3165806,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-01T20:15:57.000Z","date":"2020-04-29","kind":"grant","acquired":true,"shares":13125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company."}],"balance_after":13125,"derivative":{"exercise_price":14.56,"expiration_date":"2030-04-29","underlying":"Common Stock","underlying_shares":13125},"source":{"system":"sec-edgar","filing":"0001593968-20-001089","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396820001089/primary_01.xml","form_type":"4"}},{"id":3165805,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-05-01T20:15:57.000Z","date":"2020-04-29","kind":"exercise","acquired":false,"shares":1750,"price":14.56,"value":25480.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. The first Annual Meeting of Stockholders occurred on April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001593968-20-001089","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396820001089/primary_01.xml","form_type":"4"}},{"id":3165804,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-01T20:15:57.000Z","date":"2020-04-29","kind":"exercise","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on May 1, 2019."}],"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001593968-20-001089","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396820001089/primary_01.xml","form_type":"4"}},{"id":3360901,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T06:20:19.000Z","date":"2019-11-20","kind":"purchase","acquired":true,"shares":5800,"price":3.43,"value":19894.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase reported in this Form 4 was made on the open market."}],"balance_after":29731,"source":{"system":"sec-edgar","filing":"0001562180-19-005642","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218019005642/primarydocument.xml","form_type":"4"}},{"id":3481118,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-21T16:15:39.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4356},"source":{"system":"sec-edgar","filing":"0001179110-19-008023","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019008023/edgar.xml","form_type":"4"}},{"id":3481117,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T16:15:39.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gilman's continued service to the Company."}],"balance_after":25000,"derivative":{"exercise_price":12.64,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-19-008023","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019008023/edgar.xml","form_type":"4"}},{"id":3481116,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-21T16:15:39.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7796,"source":{"system":"sec-edgar","filing":"0001179110-19-008023","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019008023/edgar.xml","form_type":"4"}},{"id":3482547,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-20T17:32:45.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.29,"expiration_date":"2029-06-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-19-038195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119038195/doc4.xml","form_type":"4"}},{"id":3495389,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-06-10T16:04:12.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Stock Option\").  100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":4.23,"exercise_date":"2020-06-06","expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-19-003435","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218019003435/primarydocument.xml","form_type":"4"}},{"id":3495388,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-10T16:04:12.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"RSUs\").  100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":23931,"source":{"system":"sec-edgar","filing":"0001562180-19-003435","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379970/000156218019003435/primarydocument.xml","form_type":"4"}},{"id":3540838,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-05-03T20:07:46.000Z","date":"2019-05-01","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"No expiration date for this type of award."}],"balance_after":1750,"derivative":{"underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001593968-19-001035","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396819001035/primary_01.xml","form_type":"4"}},{"id":3540837,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-03T20:07:46.000Z","date":"2019-05-01","kind":"grant","acquired":true,"shares":13125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company."}],"balance_after":13125,"derivative":{"exercise_price":16.62,"exercise_date":"2019-06-01","expiration_date":"2029-05-01","underlying":"Common Stock","underlying_shares":13125},"source":{"system":"sec-edgar","filing":"0001593968-19-001035","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396819001035/primary_01.xml","form_type":"4"}},{"id":3540836,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-03T20:07:46.000Z","date":"2019-05-01","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options, representing the right to purchase a total of 15,000 shares, became exercisable in equal monthly installments, contingent upon continued service to the Company, with the first vesting date on June 4, 2016, which was one month after the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":2.76,"expiration_date":"2026-05-04","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001593968-19-001035","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396819001035/primary_01.xml","form_type":"4"}},{"id":3540835,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-03T20:07:46.000Z","date":"2019-05-01","kind":"sale","acquired":false,"shares":7500,"price":16.8126,"value":126094.5,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001593968-19-001035","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396819001035/primary_01.xml","form_type":"4"}},{"id":3540834,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":78004,"kind":"person","name":"GILMAN STEVEN C","position":1,"cik":"0001379970","reported_name":"GILMAN STEVEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-03T20:07:46.000Z","date":"2019-05-01","kind":"exercise","acquired":true,"shares":7500,"price":2.76,"value":20700.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001593968-19-001035","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396819001035/primary_01.xml","form_type":"4"}}],"next_cursor":"2019-05-03T20:07:46.000000Z,3540834"}